EAM
BIOR

Eagle Asset Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Eagle Asset Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-64
Closed -$24K – 632
2021
Q3 		$24K Hold
64
– – ﹤0.01% 589
2021
Q2 		$56K Buy
+64
New +$48.9K ﹤0.01% 591

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Eagle Asset Management's BIOR Position: Q4 2021 in Review

Eagle Asset Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2021, closing a stake of 64 shares — an estimated $24K sold.

Eagle Asset Management first reported a position in BIOR in Q2 2021 and held it in 2 quarters. The position peaked at $56K in Q2 2021. 53 funds tracked by Wall St. Rank hold BIOR as of Q4 2021.

  • Eagle Asset Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Eagle Asset Management sold 64 Biora Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $24K.
  • Eagle Asset Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Eagle Asset Management's Biora Therapeutics, Inc. Common Stock position peaked at $56K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Eagle Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.